- Rank in Search Criteria: 5181
World Rank (Jan-05-2024): 17,524
Market Cap (Jan-05-2024): 0.22 Billion USD
World Rank (Jul-30-2023): 18857
Market Cap (Jul-30-2023): 0.17 Billion USD
World Rank (Jan-2022): 19,817
Market Cap (Jan-2022): 0.17 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 5182
World Rank (Jan-05-2024): 17,524
World Rank (Jul-30-2023): 17524
Market Cap (Jul-30-2023): 0.22 Billion USD
World Rank (Jan-2022): 19,161
Market Cap (Jan-2022): 0.20 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 5183
World Rank (Jan-05-2024): 17,533
World Rank (Jul-30-2023): 17533
World Rank (Jan-2022): 18,560
Market Cap (Jan-2022): 0.22 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 5184
World Rank (Jan-05-2024): 17,534
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 16650
Market Cap (Jul-30-2023): 0.26 Billion USD
World Rank (Jan-2022): 15,856
Market Cap (Jan-2022): 0.34 Billion USDHeadquarters Country: USA Annual Revenue in USD: 89 Million USD
Annual Net Income in USD: -149 Million USD
Annual Results for Period ending: Dec-2020 ending yearEmployee Count: 48
Employee Count as of Date: As on 2021
- Rank in Search Criteria: 5185
World Rank (Jan-05-2024): 17,536
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 17794
Market Cap (Jul-30-2023): 0.21 Billion USD
World Rank (Jan-2022): 17,148
Market Cap (Jan-2022): 0.28 Billion USDHeadquarters Country: USA Annual Revenue in USD: 18 Million USD
Annual Net Income in USD: 18 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5186
World Rank (Jan-05-2024): 17,538
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 17657
Market Cap (Jul-30-2023): 0.22 Billion USD
World Rank (Jan-2022): 19,521
Market Cap (Jan-2022): 0.18 Billion USDAnnual Revenue in USD: 225 Million USD
Annual Net Income in USD: 6 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5187
World Rank (Jan-05-2024): 17,539
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 17612
Market Cap (Jul-30-2023): 0.22 Billion USD
World Rank (Jan-2022): 17,084
Market Cap (Jan-2022): 0.28 Billion USDHeadquarters Country: USA Annual Revenue in USD: -1 Million USD
Annual Net Income in USD: -2 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5188
World Rank (Jan-05-2024): 17,541
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 13604
Market Cap (Jul-30-2023): 0.44 Billion USD
World Rank (Jan-2022): 13,048
Market Cap (Jan-2022): 0.53 Billion USDHeadquarters Country: USA Annual Revenue in USD: 187 Million USD
Annual Net Income in USD: 180 Million USD
Annual Results for Period ending: Aug-2009 ending year
- Rank in Search Criteria: 5189
World Rank (Jan-05-2024): 17,546
World Rank (Jul-30-2023): 17546
World Rank (Jan-2022): 18,822
Market Cap (Jan-2022): 0.21 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 5190
World Rank (Jan-05-2024): 17,561
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 17950
Market Cap (Jul-30-2023): 0.20 Billion USD
World Rank (Jan-2022): 16,648
Market Cap (Jan-2022): 0.30 Billion USDHeadquarters Country: USA Company Profile: Lineage Cell Therapeutics is a Clinical Stage Biotechnology company developing novel cellular therapies to treat unmet medical needs. The company total assets are 107.9 million USD as on 2020. The headquarters is in USA.